Related Experiment Video
Updated: Mar 1, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Stroke in Patients with Chronic Kidney Disease…: How do we Approach and Manage it?
1Department of Nephrology, K. S. Hegde Medical Academy Medical Sciences Complex, Mangalore, Karnataka, India.
Patients with chronic kidney disease (CKD) face a significantly higher risk of stroke due to various factors. Understanding these risks is crucial for developing effective stroke prevention strategies in this population.
Area of Science:
- Nephrology
- Neurology
- Cardiovascular Medicine
Background:
- Renal failure is a major risk factor for stroke, increasing incidence and mortality.
- Patients with chronic kidney disease (CKD), particularly those on dialysis, experience a 5-30 times higher stroke risk.
- CKD patients exhibit higher stroke case fatality rates, approaching 90%.
Purpose of the Study:
- To review the factors predisposing patients with CKD to stroke.
- To discuss preventive strategies for stroke in the CKD population.
- To outline the approach to managing stroke in patients with renal failure.
Main Methods:
- This article is a review of existing literature on stroke in CKD patients.
- It synthesizes information on risk factors, pathophysiology, and management strategies.
- The review examines the interplay of comorbidities, uremic toxins, dialysis-specific factors, and therapeutic interventions.
Main Results:
- Stroke risk in CKD is multifactorial, involving vascular comorbidities and renal failure-specific issues like malnutrition-inflammation-atherosclerosis.
- Hypertension, diabetes, old age, and prior cerebrovascular disease are key risk factors, with dialysis initiation being a high-risk period.
- Thrombolytic therapy carries increased hemorrhage risk, statins show no benefit in dialysis patients, and newer anticoagulants lack data in severe CKD.
Conclusions:
- Hypertension control and judicious antiplatelet use are primary stroke prevention strategies in CKD.
- Balancing antiplatelet/anticoagulant benefits against bleeding risks is critical, especially in dialysis cohorts.
- Caution is advised with anticoagulants in CKD due to potential risks like vascular calcification and lack of data in severe renal impairment.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
Chronic Kidney Disease I: Introduction

